-
Antimicrobial Effect of Uro-vaxom? in Catheter-Related Urinary Tract Infection
-
Sun Wook Kim, Byung Il Yoon, U Syn Ha, Dong Wan Sohn, Yong Hyun Cho
-
Korean J Urogenit Tract Infect Inflamm 2012;7(2):158-163. Published online October 31, 2012
-
-
-
 Abstract
 PDF
- Purpose: Urinary tract infection (UTI) is a relatively common disease, and clinically it appears diversely like urethritis, cystitis, prostatitis, and acute pyelonephritis. E. coli which is the major causative microorganism of UTI, and accounts for 50% of hospital pathogens cultured in 40% of catheter-related UTI. We evaluated the preventive effect on UTI and inhibitory effect on complications of Uro-vaxom?, and investigate the effect of Uro-vaxom? in catheter induced UTI.
Materials and Methods: A comprehensive electronic search was conducted using the Medline database to identify all publications relating to Uro-vaxom? and catheter and UTI by using keywords Uro-vaxom?, catheter, catheterization, urinary tract infection, cystitis, bacteriuria, antimicrobial agents, intensive care unit.
Results: 227 literatures which were consistent with our purposes were searched; we intensively analyzed 26 literatures which were appropriate for our literature. All literature reported antimicrobial effects of Uro-vaxom?.
Conclusions: We identified that Uro-vaxom? had a preventive effect on UTI associated with E. coli to patients who had catheterization. (Korean J UTII 2012;7:158-163)
-
Clinical Outcome of Acute Bacterial Prostatitis; A Multicenter Study
-
Seong Ju Lee, Jin Mo Koo, Bong Suk Shim, Yong Hyun Cho, Chang Hee Han, Seung Ki Min, Sung Joo Lee, Hwan Cheol Son, Jun Mo Kim, Jong Bo Choi, Tae Hyoung Kim, Sang Kuk Yang, Kil Ho Lee, Yong Kil Na, Sung Ho Lee, Hee Jong Jung, Seung Il Jung, Chul Sung Kim, Jae Min Chung, Young Jin Seo, Won Yeol Cho, Kweon Sik Min, Sang Don Lee
-
Korean J Urogenit Tract Infect Inflamm 2011;6(2):165-170. Published online October 31, 2011
-
-
-
Abstract
PDF
- "Purpose: Proper guidelines concerning antibiotic administration for acute bacterial prostatitis (ABP) are unclear. We retrospectively analyzed treatment status and clinical outcomes to establish a proper treatment guideline. Materials and Methods: The clinical records of 669 patients from 21 hospitals diagnosed with ABP were reviewed. Prior manipulation, antibiotics administration, mean length of treatment, complication and procedure were analyzed. Results: The mean age of 538 patients (80.4%) without manipulation (group 1) and 131 patients (19.6%) with manipulation (group 2) was 58.3 years (range 19-88 years). Transrectal prostate biopsy was the most common cause of acute bacterial prostatitis (n=66; 50.4%). Of the clinical symptoms in the non-manipulation and manipulation groups, fever was most common (88.2% and 86.3%, respectively). Acute urinary retention (14.3% and 28.1%, respectively) was significantly increased in the manipulation group (p<0.05). Escherichia coli was the most frequently isolated bacterium from urine (72.0% and 66.7% of cases, respectively). Mean length of treatment was 6.5days and 7.9days, respectively; the difference was significant (p<0.05). Combination antibiotic therapy with third generation cephalosporin+aminoglycoside was used in 49.3% and 55.5% of cases, respectively. For single antibiotic therapy, second generation quinolones were used the most (35.5% and 34.3%, respectively). Sequale occurred in 29 group 1 patients (5.4%) and 20 group 2 patients (15.3%); the difference was significant (p<0.05). Conclusions: Prior manipulation was associated with 20% of ABP patients. Regardless of manipulation, clinical outcome was similar after treating with appropriate antibiotics."
|
KAUTI
